iRhythm Technologies Announces Results of GUARD-AF Trial

Go back to iRhythm Technologies Announces Results of GUARD-AF Trial

Oppenheimer Reiterates Outperform Rating on iRhythm Technologies (IRTC)

September 3, 2024 6:08 AM EDT

Oppenheimer analyst Suraj Kalia reiterated an Outperform rating and $145.00 price target on iRhythm Technologies (NASDAQ: IRTC).

The analyst comments "On Sunday (9/2), GUARD-AF trial results were presented at ESC Congress 2024, and simultaneously published online (link1/link2). The trial, which was halted prematurely due to the... More